PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 155 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $27,000 | +3.8% | 3,296 | -8.8% | 0.00% | – |
Q1 2018 | $26,000 | +85.7% | 3,614 | +56.1% | 0.00% | – |
Q4 2017 | $14,000 | -50.0% | 2,315 | -39.8% | 0.00% | – |
Q3 2017 | $28,000 | +12.0% | 3,845 | +5.1% | 0.00% | – |
Q2 2017 | $25,000 | -30.6% | 3,660 | -2.0% | 0.00% | – |
Q1 2017 | $36,000 | +12.5% | 3,734 | -0.2% | 0.00% | – |
Q4 2016 | $32,000 | – | 3,742 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|